PMC5605293

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients with clinically significant depression or anxiety were significantly more likely to prefer the PHQ be used at future outpatient visits (depression OR = 3.88, P = 0.02; anxiety OR = 17.6, P =

Effect: improvement; OR = 3.88 (depression); OR = 17.6 (anxiety); CI: 95% CI 1.27-11.9 (depression); 95% CI 2.18-142.3 (anxiety)

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%

Patients in the experimental group who had PHQ results reviewed by their provider before the visit were significantly more likely to have discussion of psychological symptoms than the control group (6

Effect: improvement; 68% versus 49%